PharmiWeb.com - Global Pharma News & Resources
15-Jun-2019

Peptic Ulcer Drugs Market 2019 Worldwide Growth, Trends and Forecasts (2019-2024)

Market Research Engine has published a new report titled asPeptic Ulcer Drugs Market By Product (Proton Pump Inhibitors, Potassium-Competitive Acid Blockers, Antacids, H2-Antagonists, Antibiotics, Ulcer Protective Drugs); By Application (Hospital Pharmacies, Private Clinics, Drug Stores, Retail Pharmacies, E-Commerce) and by Regional Analysis - Global Forecast by 2018 – 2024. 

The Peptic Ulcer Drugs Market is expected to exceed more than US$ 36.00 Billion by 2024 at a CAGR of 3.8% in the given forecast period.

Browse Full Report: https://www.marketresearchengine.com/peptic-ulcer-drugs-market

Report scope:

The scope of the report includes a detailed study of Peptic Ulcer Drugs Market with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Daewoong Pharmaceutical, Takeda Pharmaceutical, Pfizer, Abbott Laboratories, AstraZeneca, Cadila Healthcare, Boehringer Ingelheim, Eisai, Yuhan and GlaxoSmithKline Pharmaceuticals. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments. 

The Peptic Ulcer Drugs Market is segmented on the lines of its product, application and regional. On the basis of product segmentation, it covert Proton Pump Inhibitors, Potassium-Competitive, Acid Blockers, Antacids, H2-Antagonists, Antibiotics and Ulcer Protective Drugs. Based on application classification it includes Hospital Pharmacies, Private Clinics, Drug Stores, Retail Pharmacies and E-Commerce. The Peptic Ulcer Drugs Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, and Rest of World. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

A peptic ulcer is an open injury that creates on the mucosal coating of the stomach and small digestive system due to the scathing impact of the gastric acids and compounds in these organs. The side effects of peptic ulcers are torment in the midriff, sickness, spewing, and enlarged stomach. The significant manifestations incorporate seeping from the ulcer, which can be dangerous. It is identified by bleeding and sticky stools, regularly dark in shading. Peptic ulcers are caused for the most part by a Helicobacter pylori contamination pursued by the abuse of OTC NSAIDs, for example, Naproxen, Aspirin and Ibuprofen. Peptic ulcers can be of two sorts dependent on the site of the ulcer: gastric ulcer and duodenal ulcer. 

The major driving factors of Peptic Ulcer Drugs Market are as follows:

  • Growing aging population
  • R&D investments and advancements in peptic ulcer therapies
  • Economics of treating ulcer

The major restraining factors of Peptic Ulcer Drugs Market are as follows:

  • Rising adverse effect of proton pump inhibitors
  • Patent expiration of various drugs
  • Changes in pricing policies of drugs

The major opportunities of Peptic Ulcer Drugs Market are as follows:

  • Continuous growth as there has been rise in the number of patients in developing
  • Bismuth-based quadruple therapy

The Peptic Ulcer Drugs Market has been segmented as below:

By Product:

  • Proton Pump Inhibitors
  • Potassium-Competitive Acid Blockers
  • Antacids
  • H2-Antagonists
  • Antibiotics
  • Ulcer Protective Drugs

By Application:

  • Hospital Pharmacies
  • Private Clinics
  • Drug Stores
  • Retail Pharmacies
  • E-Commerce

 By Regional Analysis:

  •     North America
  •     Europe
  •     Asia-Pacific
  •     Rest of the World

This report provides:

1) An overview of the global market for Peptic Ulcer Drugs Market and related technologies.
2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2024.
3) Identifications of new market opportunities and targeted promotional plans Peptic Ulcer Drugs Market

4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry. 

Reasons to Buy this Report:

  1. Obtain the most up to date information available on all Peptic Ulcer Drugs Market.
  2. Identify growth segments and opportunities in the industry.
  3. Facilitate decision making on the basis of strong historic and forecast of Peptic Ulcer Drugs Market.
  4. Assess your competitor’s refining portfolio and its evolution.

Request Sample Report from here: https://www.marketresearchengine.com/peptic-ulcer-drugs-market

 

Table of Contents:

  1. Introduction
  2. Research Methodology
  3. Report Summary
  4. Market Overview

    4.1    Introduction

    4.2    Drivers

    4.3    Restrains

    4.4    Industry Trends

    4.5    Porter’s Five Forces Analysis

  1. Peptic Ulcer Drugs Market Analysis, By Product
  2. Peptic Ulcer Drugs Market Analysis, By Application
  3. Peptic Ulcer Drugs Market Analysis, By Region
  4. Competitive Overview
  5. Company Profiles

    9.1    Abbott Laboratories

    9.2    AstraZeneca

    9.3    GlaxoSmithKline Pharmaceuticals

    9.4    Daewoong Pharmaceutical

    9.5    Takeda Pharmaceutical

    9.6    Pfizer

    9.7    Cadila Healthcare

    9.8    Boehringer Ingelheim

    9.9    Eisai

    9.10    Yuhan

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: john@marketresearchengine.com

Phone: +1-855-984-1862

Country: United States

Website: https://www.marketresearchengine.com/

Editor Details

Related Links

Last Updated: 18-Jun-2019